Fusion Antibodies PLC

BiVictrix Therapeutics Plc

The company develops selective antibody-drug conjugates for the treatment of various cancers, including liquid and solid tumours, for the pharmaceutical and clinical sectors.

Pheon Therapeutics

The company develops antibody-drug conjugates to treat solid tumours for the healthcare and pharmaceutical sectors.

ABL Bio

The company develops bispecific antibody therapeutics for immuno-oncology and neurodegenerative diseases for pharmaceutical partners and clinical research applications.

Nextera

This company develops antibody therapies and drug targets for pharmaceutical organisations treating cancer, autoimmunity and inflammatory diseases.

Crescendo Biologics

This company develops antibody fragment therapeutics for oncology and immunology patients and provides drug discovery collaborations to global biopharmaceutical partners.

Protillion Biosciences

This company develops a high-throughput protein engineering platform for pharmaceutical partners to accelerate the discovery and optimisation of therapeutic antibodies and binder drugs.

Abzena

This company provides discovery, development and manufacturing services for biologics and bioconjugates to biotechnology and pharmaceutical customers.

Antiverse

This company uses generative AI to design functional antibody biologics for pharmaceutical organisations targeting complex medical conditions and transmembrane proteins.